, European Monitoring Centre for Drugs and Drug Addiction, Europol. Methamphetamine: a European Union perspective in the global context, EMCDDA | interactive source table, vol.1, 2009.
Clinical effects and management of methamphetamine abuse, Pharmacotherapy. août, vol.26, issue.8, pp.1148-56, 2006. ,
History of the Methamphetamine Problem, J Psychoactive Drugs. 1 juin, vol.32, issue.2, pp.137-178, 2000. ,
Les junkies d'Hitler : La Pervitine (méthamphétamine) dans l'Allemagne Nazie et la Wehrmacht. Diffusé sur RMC découverte et LCP ,
,
Amphetamines: An Update on Forensic Issues, J Anal Toxicol. 1 juill, vol.25, issue.5, pp.400-404, 2001. ,
MARTINDALE -Complete Drug Ref, p.4 ,
, Terminology and information on drugs. Vienna: Publishing and Library Section, United Nations O ce, 2016.
Dépendance à la méthamphétamine : de nombreuses conséquences et complications, Presse Médicale. déc, vol.39, issue.12, pp.1246-53, 2010. ,
DARK Classics in chemical neuroscience: methamphetamine, ACS Chem Neurosci. 6 avr, vol.9, issue.10, pp.2373-2381, 2018. ,
, Exploring methamphetamine trends in Europe, EMCDDA Papers, Publications Office of the European Union, EMCDDA, 2014.
Synthetic reductions in clandestine amphetamine and methamphetamine laboratories: A review, Forensic Sci Int. août, vol.42, issue.3, pp.183-99, 1989. ,
Methamphetamine from ephedrine: I. chloroephedrines and aziridines, J Forensic Sci. 1 juill, vol.32, issue.4, pp.953-62, 1987. ,
Characterization of Route Specific Impurities Found in Methamphetamine Synthesized by the Leuckart and Reductive Amination Methods, Anal Chem. sept, vol.81, issue.17, pp.7342-7350, 2009. ,
A review of the clinical pharmacology of methamphetamine, Addiction. Fev, vol.104, issue.7, pp.1085-99, 2009. ,
Methamphetamine: an update on epidemiology, pharmacology, clinical phenomenology, and treatment literature, Drug Alcohol Depend, vol.1, issue.0, pp.11-21, 2015. ,
Neurologic manifestations of chronic methamphetamine abuse, Neurol Clin. août, vol.29, issue.3, pp.641-55, 2011. ,
, United Nations Publications. World Drug Report, 2017.
Methamphetamine continues to dominate synthetic drug markets, Global SMART Update, vol.20, 2018. ,
, European Monitoring Centre for Drugs and Drug Addiction, éditeur. Problem amphetamine and methamphetamine use in Europe. Luxembourg: Publ. Office of the European Union, vol.35, 2010.
Methamphetamine abuse and impairment of social functioning: A review of the underlying neurophysiological causes and behavioral implications, Psychol Bull, vol.134, issue.2, pp.301-311, 2008. ,
Neuropsychiatric adverse effects of amphetamine and methamphetamine, International Review of Neurobiology, pp.179-204, 2015. ,
Mechanisms of neurotransmitter release by amphetamines: A review, Prog Neurobiol. avr, vol.75, issue.6, pp.406-439, 2005. ,
How Addictive Drugs Disrupt Presynaptic Dopamine Neurotransmission, Neuron. Fev, vol.69, issue.4, pp.628-677, 2011. ,
Interplay between cytosolic dopamine, calcium, and ?-synuclein causes selective death of substantia nigra neurons, Neuron. 30 avr, vol.62, issue.2, pp.218-247, 2009. ,
Vesicular monoamine transporters: Structure-function, pharmacology, and medicinal chemistry, Med Res Rev. juill, vol.31, issue.4, pp.483-519, 2011. ,
Pharmacologic mechanisms of crystal meth, Can Med Assoc J. 17 juin, vol.178, issue.13, pp.1679-82, 2008. ,
Vesicular monoamine transporter 2 regulates the sensitivity of rat dopaminergic neurons to disturbed cytosolic dopamine levels, Brain Res. déc, vol.1185, pp.18-32, 2007. ,
Reduced Striatal Dopamine Transporter Density in Abstinent Methamphetamine and Methcathinone Users: Evidence from Positron Emission Tomography Studies with [11C]WIN-35,428, J Neurosci, vol.18, issue.20, pp.8417-8439, 1998. ,
The locus coeruleus-noradrenergic system: modulation of behavioral state and state-dependent cognitive processes, Brain Res Rev. avr, vol.42, issue.1, pp.33-84, 2003. ,
Berridge CW. Neural substrates of psychostimulant-induced arousal, Neuropsychopharmacology, vol.26, issue.4, pp.2332-2372, 2003. ,
The experimental reproduction of amphetamine psychosis, Arch Gen Psychiatry. 1 juill, vol.29, issue.1, pp.35-40, 1973. ,
Methamphetamine-related sudden death with a concentration which was of a 'toxic level', Leg Med. mai, vol.8, issue.3, pp.150-155, 2006. ,
Toxicological and histopathological analysis of a patient who died nine days after a single intravenous dose of methamphetamine: A case report, Leg Med. juill, vol.8, issue.4, pp.235-244, 2006. ,
Cardiomyopathy associated with amphetamine administration, Am Heart J. juin, vol.91, issue.6, pp.792-799, 1976. ,
Intracranial hemorrhage and amphetamine usage: review of the effects of amphetamines on the central nervous system, Angiology. juill, vol.28, issue.7, pp.464-71, 1977. ,
An autopsy case of subarachnoid and intracerebral hemorrhage and necrotizing angitis associated with methamphetamine abuse. No Shinkei, vol.40, pp.1089-94, 1988. ,
Immunohistochemical study of myoglobin and oxidative injury-related markers in the kidney of methamphetamine abusers, Leg Med. mars, vol.5, issue.1, pp.42-50, 2003. ,
A fatal methamphetamine poisoning associated with hyperpyrexia, Forensic Sci Int, vol.24, pp.87-93, 1984. ,
Amphetamine Poisoning Associated with Hyperpyrexia, Br Med J. 17 sept, vol.2, issue.5202, pp.844-844, 1960. ,
Death in amphetamine users: causes and rates, CMA J. Fev, vol.112, pp.299-304, 1975. ,
Cause and manner of death in fatalities involving methamphetamine, J Forensic Sci. janv, vol.43, issue.1, pp.28-34, 1998. ,
What is the real distribution of methamphetamine-related causes of death ?, Addiction. déc, vol.112, issue.12, pp.2202-2207, 2017. ,
Methamphetamine abuse and dentistry, Oral Dis. janv, vol.15, issue.1, pp.27-37, 2009. ,
Frequency of acute coronary syndrome in patients presenting to the Emergency Department with chest pain after methamphetamine use, J Emerg Med. mai, vol.24, issue.4, pp.369-73, 2003. ,
The cardiac complications of methamphetamines, Heart Lung Circ. avr, vol.25, issue.4, pp.325-357, 2016. ,
Methamphetamine and cardiovascular pathology: a review of the evidence, Addiction. août, vol.102, issue.8, pp.1204-1215, 2007. ,
Hypertensive heart disease associated with methamphetamine abuse, J Cardiol Cases. févr, vol.19, issue.2, pp.47-50, 2019. ,
Spontaneous intracerebral hemorrhage related to methamphetamine abuse: autopsy findings and clinical correlation, Am J Forensic Med Pathol. déc, vol.25, issue.4, pp.334-341, 2004. ,
Methamphetamine as a risk factor for acute aortic dissection, J Forensic Sci. janv, vol.44, issue.1, pp.23-29, 1999. ,
The emerging epidemic of methamphetamineinduced aortic dissections, J Card Surg. sept, vol.22, issue.5, pp.390-393, 2007. ,
Methamphetamine and the risk of pulmonary arterial hypertension, Curr Opin Pulm Med. sept, vol.24, issue.5, pp.416-440, 2018. ,
Features and Outcomes of Methamphetamine-associated Pulmonary Arterial Hypertension, Am J Respir Crit Care Med. 15 mars, vol.197, issue.6, pp.788-800, 2018. ,
Is methamphetamine use associated with idiopathic pulmonary arterial hypertension ?, Chest. déc, vol.130, issue.6, pp.1657-63, 2006. ,
Clinical characteristics, histopathological features, and clinical outcome of methamphetamine-associated cardiomyopathy, JACC Heart Fail. juin, vol.5, issue.6, pp.435-480, 2017. ,
The association of methamphetamine use and cardiomyopathy in young patients, Am J Med. févr, vol.120, issue.2, pp.165-71, 2007. ,
Meth Mouth-A Growing Epidemic in Dentistry? Dent J, vol.5, p.29, 2017. ,
Methamphetamine abuse and meth mouth in Europe, Med Oral Patol Oral Cir Bucal. 1 mai, vol.20, issue.2, p.1491, 2005. ,
The effect of methamphetamine abuse on dental caries and periodontal diseases in an Eastern China city, BMC Oral Health. déc, vol.18, issue.1, pp.1-6, 2018. ,
Etiology of Xerostomia and Dental Caries among Methamphetamine Abusers. Oral Health Prev Dent, vol.3, pp.189-95, 2005. ,
Methamphetamine and its impact on dental care, J Can Dent Assoc, vol.71, issue.10, pp.759-62, 2005. ,
, m%C3%A9decine)&oldid=155169031 65. Bruxisme. In: Wikipédia [Internet, 2018.
Osteonecrosis of the maxilla related to longstanding methamphetamine abuse: a possible new aspect in the etiology of osteonecrosis of the jaw, Oral Maxillofac Surg. juin, vol.18, issue.2, pp.237-278, 2014. ,
, Pathways of Methamphetamine Toxicity
, Ann N Y Acad Sci, vol.1139, issue.1, pp.177-85, 2008.
Brain Dopamine Neurotoxicity in Baboons Treated with Doses of Methamphetamine Comparable to Those Recreationally Abused by Humans: Evidence from [11C]WIN-35,428 Positron Emission Tomography Studies and Direct In Vitro Determinations, J Neurosci. 1 janv, vol.18, issue.1, pp.419-446, 1998. ,
Recovery from methamphetamine induced longterm nigrostriatal dopaminergic deficits without substantia nigra cell loss, Brain Res. juill, vol.871, issue.2, pp.259-70, 2000. ,
Structural abnormality of substantia nigra induced by methamphetamine abuse: Abnormality of SN Induced by Methamphetamine, Mov Disord. déc, vol.32, issue.12, pp.1784-1792, 2017. ,
Chronic methamphetamine abuse and corticostriatal deficits revealed by neuroimaging, Brain Res. 2 déc, vol.1628, pp.174-85, 2015. ,
Neurobiologie de l'addiction : proposition d'un nouveau concept, Inf Psychiatr. Fev, vol.83, issue.2, pp.91-98, 2007. ,
The prevalence of psychotic symptoms among methamphetamine users. Addiction, vol.101, pp.1473-1481, 2006. ,
Diagnostic And Statistical Manual of Mental Disorders : DSM-5. VA, 2013. ,
A Neural Substrate of Prediction and Reward, Science. 14 mars, vol.275, issue.5306, pp.1593-1602, 1997. ,
Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats, Proc Natl Acad Sci U A. 1 juill, vol.85, issue.14, pp.5274-5282, 1988. ,
Why is parkinsonism not a feature of human methamphetamine users? Brain, Fev, vol.127, issue.2, pp.363-70, 2004. ,
Alpha1b-adrenergic receptors control locomotor and rewarding effects of psychostimulants and opiates, J Neurosci Off J Soc Neurosci. 1 avr, vol.22, issue.7, pp.2873-84, 2002. ,
5-HT2A and ?1b-adrenergic receptors entirely mediate dopamine release, locomotor response and behavioural sensitization to opiates and psychostimulants: 5-HT2A and ?1b-AR mediate behavioural sensitization, Eur J Neurosci. 2 déc, vol.20, issue.11, pp.3073-84, 2004. ,
Importance of the noradrenaline-dopamine coupling in the locomotor activating effects of d-amphetamine, J Neurosci. 1 avr, vol.18, issue.7, 1998. ,
, MÉTAMPHÉTAMINES [Desoxyn® (USA), Méthédrine® (ANG), Pervitin®(ALL), Tonédron® (FRA)
, , 1972.
, Precursors and chemicals frequently used in the illicit manufacture of narcotic drugs and psychotropic substances, United Nations Office, 2017.
Impacts of federal ephedrine and pseudoephedrine regulations on methamphetamine-related hospital admissions, Addiction. sept, vol.98, issue.9, pp.1229-1266, 2003. ,
,
Autorisation -Minigraphie HUMEX Rhinite Allergique ,
, 88. AFSSAPS. Commission nationale des stupéfiants et des psychotropes. Compte-rendu de la 79ième réunion du 17 avril, vol.18, 2008.
Quite a lot of smoke but very limited fire -the use of methamphetamine in Europe, Drug Alcohol Rev. mai, vol.27, issue.3, pp.236-278, 2008. ,
Perspectives on drugs, Synthetic drug production, 2013. ,
, Illicit manufacture. Number of clandestine laboratories detected, 2011.
, Observatoire européen des drogues et des toxicomanies, editor. Rapport européen sur les drogues 2018: Tendances et évolutions. Office des publications de l'Union européenne, p.96, 2018.
, United Nations Publications. World Drug Report, 2018.
Recent trends in the availability and use of amphetamine and methamphetamine in Norway, Forensic Sci Int. janv, vol.246, pp.92-99, 2015. ,
The management of methamphetamine use in sexual settings among men who have sex with men in Malaysia, Int J Drug Policy. mai, vol.55, pp.256-62, 2018. ,
Longitudinal investigation of methamphetamine use among gay and bisexual men in New York city: findings from project BUMPS, J Urban Health Bull N Y Acad Med. 28 févr, vol.82, issue.1, pp.18-25, 2005. ,
Amphetamine-type stimulants and HIV infection among men who have sex with men: implications on HIV research and prevention from a systematic review and meta-analysis, J Int AIDS Soc. Fev, vol.18, issue.1, p.19273, 2015. ,
Crystal meth : une forme de méthamphétamine, Presse Médicale. janv, vol.38, issue.1, pp.63-70, 2009. ,
Use of crystal methamphetamine among gay men in London. Addiction, vol.101, pp.1622-1652, 2006. ,
Risques liés à la pratique du ChemSex, 2018. ,
Perspectives on drugs, Health and social responses for methamphetamine users, 2014. ,
Characteristics and harms associated with injecting versus smoking methamphetamine among methamphetamine treatment entrants, Drug Alcohol Rev. mai, vol.27, issue.3, pp.277-85, 2008. ,
en présence des maîtres de la Faculté, des conseillers de l'ordre des Pharmaciens et de mes condisciples : D'honorer ceux qui m'ont instruit(e) dans les préceptes de mon art et de leur témoigner ma reconnaissance en restant fidèle à leur enseignement ,
, intérêt de la santé publique, ma profession avec conscience et de respecter non seulement la législation en vigueur, mais aussi les règles de l'honneur
, De ne jamais oublier ma responsabilité et mes devoirs envers le malade et sa dignité humaine
, En aucun cas, je ne consentirai à utiliser mes connaissances et mon état pour corrompre les moeurs et favoriser des actes criminels
, Que les hommes m'accordent leur estime si je suis fidèle à mes promesses
, Que je sois couvert(e) d'opprobre et méprisé(e) de mes confrères si j'y manque